wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33881234-A6CB0784-1954-41ED-9BA4-78AFD61AAD9B
Q33881234-A6CB0784-1954-41ED-9BA4-78AFD61AAD9B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33881234-A6CB0784-1954-41ED-9BA4-78AFD61AAD9B
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability.
P2860
Q33881234-A6CB0784-1954-41ED-9BA4-78AFD61AAD9B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33881234-A6CB0784-1954-41ED-9BA4-78AFD61AAD9B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b347476f8861f80ea58d5dcdcaa6e8cd512f92fb
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.